---
$id: https://graph.org.ai/products/commodity/51384613
$type: Product
source: UNSPSC
code: "51384613"
title: "Lonazolac"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lonazolac

**UNSPSC Code**: 51384613
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H13ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 13097143QI, chemically known as 1h-pyrazole-4-acetic acid, 3-(4-chlorophenyl)-1-phenyl- but generally known as lonazolac, which bears US NIH Compound Identifier 68706. European Medicines Agency schedules Lonazolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08570MIG. The term LONAZOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules lonazolac in its Anatomical Therapeutic Chemical (ATC) Classification. LONAZOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lonazolac under HS 29331990 and SITC 51571. As of Q4 2014, LONAZOLAC remains the US FDA Preferred Term for this commodity. Lonazolac bears US NLM identifiers UMLS ID C0065166 and NCI Concept Code C66031. SMILES: CLC1CCC(C2NN(CC2CC(=O)O)C2CCCCC2)CC1.

